Effects of Long-Term Intravenous Administration of Adrenomedullin (AM) Plus hANP Therapy in Acute Decompensated Heart Failure A Pilot Study
Toshio Nishikimi(Kyoto University), Hiroaki Matsuoka(Social Welfare Department), Chikako Inaba(Dokkyo Medical University), Fumiki Yoshihara(National Cerebral and Cardiovascular Center), Tsuyoshi Karasawa(Dokkyo Medical University), Kimihiko Ishimura(Dokkyo University), Kazuyoshi Tadokoro(Dokkyo Medical University), Noritoshi Nagaya(National Cerebral and Cardiovascular Center), Shogo Koshikawa(Dokkyo Medical University), Kenji Kangawa(National Cerebral and Cardiovascular Center), Hideaki Sakio(Dokkyo Medical University)
Cited by 41
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478